Phase II INCB024360 Study for Patients With Myelodysplastic Syndromes (MDS)

Summary

The primary purpose of this research study is to assess whether the participant's disease, Myelodysplastic Syndromes (MDS), responds favorably to INCB024360. The study will also evaluate the long-term outcomes of the participant's disease after they have finished taking INCB024360.

Timeline

Start

2013-07

Primary completion

2015-01

Completion

2015-02

Drugs

Indications